Skip to main content
. Author manuscript; available in PMC: 2016 Jun 8.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Feb 6;22(5):895–901. doi: 10.1016/j.bbmt.2016.02.001

Figure 1.

Figure 1

Preparatory regimens, including (A) alemtuzumab, fludarabine, melphalan, total body irradiation (TBI); (B) alemtuzumab, fludarabine, and melphalan; (C) alemtuzumab, fludarabine, TBI. Cy = cyclophosphamide; G-CSG = granulocyte colony stimulating factor; MMF = mycophenolate mofetil; TBI = total body irradiation.